Amicus Therapeutics (0HF9.L) Stock Price
$7.63 1.3%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Amicus Therapeutics, AI stock picks, stock alerts and much more.
0HF9.L AI Stock Analysis
AI stock analysis for 0HF9.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Amicus Therapeutics (0HF9.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Amicus Therapeutics (0HF9.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Amicus Therapeutics (0HF9.L), currently trading at $7.63, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0HF9.L
-
Amicus Therapeutics, Inc.
-
Symbol
0HF9.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
2.2B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$398.5 0.5% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$136.1 1.2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.46 2.9% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.25 1.7% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.17 0.5% |
5 |
News
0HF9.L Alternative Data
Web Traffic
Amicus Therapeutics receives an estimated 18165 monthly visitors to amicusrx.com.
-
Web Traffic
18165
-
Change from Previous Month
2.2%
-
3 Month Change
19.1%
-
YoY Change
19.1%
Facebook Engagement
Amicus Therapeutics has engaged 3 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
3
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
50%
Youtube Subscribers
Amicus Therapeutics has 106 subscribers on its main Youtube channel, up by 1% over the last month.
-
Youtube Subscribers
106
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Job Postings
Amicus Therapeutics currenly has an estimated 16 open job postings.
-
Job Postings
16
-
Daily Change
5.9%
-
1 Month Change
0%
-
3 Month Change
33.3%
-
YoY Change
33.3%
Reddit Mentions
Amicus Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Amicus Therapeutics has 2,165 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
2165
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.7%
-
YoY Change
0.7%
LinkedIn Followers
50,248 are following Amicus Therapeutics on LinkedIn, up by 2.2% over the last month.
-
LinkedIn Followers
50248
-
Daily Change
2.2%
-
1 Month Change
2.2%
-
3 Month Change
6.9%
-
YoY Change
6.9%
LinkedIn Employees
According to LinkedIn, Amicus Therapeutics has 616 employees.
-
LinkedIn Employees
616
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.7%
-
YoY Change
0.7%
Business Outlook
According to employee reviews, the business outlook among employees at Amicus Therapeutics is 74 out of 100 (bullish).
-
Business Outlook
74
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Amicus Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0HF9.L Financials
0HF9.L Key Metrics
-
Total Revenue
$125.2M
-
Net Income
-$21.7M
-
Earnings per Share
-$0.07
-
Free cash flow
$7.5M
-
EBITDA
-$4.8M
-
EBITDA Ratio
-0.0379484
-
Total Assets
$789.8M
0HF9.L 2-year Revenue & Income
0HF9.L 2-year Free Cash Flow
0HF9.L Technicals
0HF9.L SMA
0HF9.L RSI
FAQ
What's the current price of Amicus Therapeutics (0HF9.L) Stock?
The price of an Amicus Therapeutics (0HF9.L) share is $7.63.
What's the market cap of Amicus Therapeutics?
The current market cap of Amicus Therapeutics is 2.2B.
Should I buy or sell 0HF9.L?
Amicus Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Amicus Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Amicus Therapeutics a good investment?
The current analysis of Amicus Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Amicus Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Amicus Therapeutics (0HF9.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Amicus Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Amicus Therapeutics (0HF9.L) that investors often compare it to?
Amicus Therapeutics (0HF9.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Amicus Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Amicus Therapeutics' stock price to be around $7.97 in 2026. Starting from the current price of $7.63, this represents a 4.5% change in price, indicating a neutral outlook for the stock.
How to buy Amicus Therapeutics (0HF9.L) Stock?
Amicus Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Amicus Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.